Table 2.
Clinical Characteristics of Entire Study Cohort
| Diabetes (n = 161) | No Diabetes (n = 1426) | P | |
|---|---|---|---|
| Age, y | 51.7 (19.9) | 34.0 (15.0) | < .0001 |
| Sex, female % | 60.0% | 57.8% | .52 |
| IGI30, pmol/mmol | 69.2 (85.4) | 142.7 (153.5) | .0002 |
| M, µmol·min–1·m–2 | 742.7 (351.4) | 1250.1 (821.5) | < .0001 |
| MCRI, ml·m–2·min–1 | 434.5 (123.3) | 456.6 (140.1) | .0008 |
| BMI, kg/m2 | 30.7 (7.9) | 28.1 (6.6) | < .0001 |
| BAI, % | 34.1 (10.2) | 31.7 (8.5) | < .0001 |
| Body fat, kg | 26.5 (15.6) | 23.7 (11.2) | .006 |
| HDL-C, mmol/l | 1.11 (0.41) | 1.19 (0.39) | .03 |
| Triglycerides, mmol/l | 1.66 (1.29) | 1.16 (0.96) | < .0001 |
Data are median (interquartile range) except for sex. Body fat and IGI30 were available only in Mexican-American Coronary Artery Disease cohort participants.
Abbreviations: BAI, body adiposity index; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; IGI30, insulinogenic index at 30 minutes; M, glucose infusion rate; MCRI, metabolic clearance rate of insulin.